Stay updated with breaking news from Christopher Frates. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
CONSHOHOCKEN, Pa., Feb. 06, 2024 -- Madrigal Pharmaceuticals, Inc. , a clinical-stage biopharmaceutical company pursuing novel therapeutics for nonalcoholic steatohepatitis , today announced that...
$259 Million in Equity Securities Sales and $50 Million in Additional Debt Financing CapacityMadrigal intends to submit a new drug application for resmetirom in the first half of 2023 CONSHOHOCKEN,... | December 21, 2022
Madrigal Pharmaceuticals Initiates the MAESTRO-NASH Outcomes Study Evaluating Resmetirom for the Treatment of Patients with Compensated NASH Cirrhosis - read this article along with other careers information, tips and advice on BioSpace
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Press release content from Globe Newswire. The AP news staff was not involved in its creation. Intercept Appoints Jared M. Freedberg as General Counsel and Secretary Intercept Pharmaceuticals, Inc.January 11, 2021 GMT NEW YORK, Jan. 11, 2021 (GLOBE NEWSWIRE) -- Intercept Pharmaceuticals, Inc. (Nasdaq:ICPT), a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive non-viral liver diseases, today announced the appointment of Jared M. Freedberg as General Counsel and Secretary. Mr. Freedberg joins Intercept from Immunomedics, Inc., w...